Evidence map›Paper›PMID 30597624›Full record

ArticleAnnals of neurology2019

Longitudinal tau accumulation and atrophy in aging and alzheimer disease.

Theresa M Harrison, Renaud La Joie, Anne Maass, Suzanne L Baker, Kaitlin Swinnerton, Laura Fenton, Taylor J Mellinger, Lauren Edwards, Julie Pham, Bruce L Miller and 2 more

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed, 1 pooled it
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 1 synthesis or guideline pooled it, 280 citations in OpenAlex.

  1. Pooled it
  2. Evaluation of [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Trial
  3. Article
  4. Tracking the Continuous Time Dynamics of Tau and Depressive Symptoms across the Alzheimer's Disease Continuum.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Correlation between in vivoAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. The Role of Amyloid-β and Tau PET in the New Era of Alzheimer Disease Therapies.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Review
  13. Article
  14. Spatial patterns of tau accumulation across the Alzheimer's disease spectrum.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Utility ofAlzheimer's research & therapy · 2025
    Article
  19. Review
  20. Intracranial stenosis and longitudinal progression of Alzheimer's disease pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Theresa M HarrisonHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA.ORCID 0000-0002-2036-3496
Renaud La JoieMemory and Aging Center, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-2581-8100
Anne MaassHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA.
Suzanne L BakerLawrence Berkeley National Laboratory, Berkeley, CA.
Kaitlin SwinnertonHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA.
Laura FentonHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA.
Taylor J MellingerMemory and Aging Center, University of California, San Francisco, San Francisco, CA.
Lauren EdwardsMemory and Aging Center, University of California, San Francisco, San Francisco, CA.
Julie PhamMemory and Aging Center, University of California, San Francisco, San Francisco, CA.
Bruce L MillerMemory and Aging Center, University of California, San Francisco, San Francisco, CA.
Gil D RabinoviciMemory and Aging Center, University of California, San Francisco, San Francisco, CA.
William J JagustHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA.
University of California, San Francisco · USUniversity of California, Berkeley · USLawrence Berkeley National Laboratory · USGerman Center for Neurodegenerative Diseases · DE

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI BRUCE L MILLER · 2002 to 2026
$67.2M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOWARD J ROSEN · 2019 to 2026
$36.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
Training in Basic Research on Aging and Age-Related DiseaseT32AG000266 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Lisa M Ellerby · 1998 to 2026
$13.8M
Neural and Biochemical Mechanisms of Cognitive AgingR01AG034570 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI William J. Jagust · 2009 to 2026
$12.0M
Mechanisms of Alzheimer's Disease Progression in the Aging BrainR01AG062542 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI JAGUST, WILLIAM J. · 2019 to 2023
$4.2M
Early Age-of-Onset AD: Clinical Heterogeneity and Network DegenerationR01AG045611 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RABINOVICI, GIL DAN · 2014 to 2018
$3.1M
Tracking Tau with In Vivo Braak Staging: Longitudinal Analysis of Tau Pathology and Functional Sequelae in Cognitively Healthy Older AdultsF32AG057107 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARRISON, THERESA M. · 2017 to 2020
$124k
Alzheimer's Association 16-443577Alzheimer's Association Research Fellowship 16-443577Helmholtz-Gemeinschaft PD-306Helmholtz Postdoc Program PD-306NIA NIH HHS F32 AG057107NIA NIH HHS P01 AG019724NIA NIH HHS P01-AG1972403NIA NIH HHS P30 AG062422NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG034570NIA NIH HHS R01 AG045611NIA NIH HHS R01 AG062542NIA NIH HHS T32 AG000266Tau Consortium
6 · The paper itself

Abstract

objectiveTo determine the rate of tau accumulation in healthy older adults (OA) and patients with Alzheimer disease (AD), as well as the relationship of tau accumulation to cortical atrophy.

methodsTwo longitudinal flortaucipir (FTP) positron emission tomography (PET) and magnetic resonance imaging (MRI) scans were acquired from 42 OA (21 Pittsburg compound B [PiB]

resultsVoxelwise FTP change in AD showed the greatest increases in lateral and medial frontal lobes. Atrophy over the same interval was more widespread and included posteromedial cortical areas, where tau accumulation rates were lower. In OA, FTP binding increased in bilateral temporal lobe and retrosplenial cortex, accompanied by atrophy in the same regions. There were no associations between voxelwise change in FTP and sex, PiB, or APOE. Regional FTP significantly increased at follow-up in OA and patients with AD. Mixed effects models showed greater FTP increases in AD compared to OA, and no differences within OA based on PiB status.

interpretationOur findings indicate that tau accumulates even in amyloid-negative healthy OA and this process can be measured with in vivo tau-PET. In OA, tau accumulation and atrophy share a similar topography. In AD, tau increases more rapidly and accumulation occurs in frontal regions that are not yet undergoing significant atrophy. Ann Neurol 2019; 1-12 ANN NEUROL 2019;85:229-240.

Indexed as

AgedAged, 80 and overAgingAlzheimer DiseaseAniline CompoundsAtrophyBrainCarbolinesCase-Control StudiesCerebral CortexContrast MediaFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMale2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleAniline CompoundsCarbolinesContrast MediaMAPT protein, humantau ProteinsThiazoles

Identifiers

PMID30597624
PMCPMC6579738
OpenAlexW2907061143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.